The invention relates to a pharmaceutical composition for treating alcohol dependency in humans, which includes two active principles: a compound having antagonist action on the 5-HT2 serotonin receptors, selected as cyproheptadine; and a compound having antagonist action on the alpha-1 noradrenergic receptors, selected among prazosin, alfuzosin, terazosin and tamsulosin.